273 related articles for article (PubMed ID: 26962798)
41. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
42. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
[No Abstract] [Full Text] [Related]
43. Preoperative elevation of carcinoembryonic antigen predicts poor tumor response and frequent distant recurrence for patients with rectal cancer who receive preoperative chemoradiotherapy and total mesorectal excision: a multi-institutional analysis in an Asian population.
Lee JH; Kim SH; Jang HS; Chung HJ; Oh ST; Lee DS; Kim JG
Int J Colorectal Dis; 2013 Apr; 28(4):511-7. PubMed ID: 23208008
[TBL] [Abstract][Full Text] [Related]
44. The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiation.
Tawfik B; Mokdad AA; Patel PM; Li HC; Huerta S
Anticancer Drugs; 2016 Oct; 27(9):879-83. PubMed ID: 27434664
[TBL] [Abstract][Full Text] [Related]
45. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
Kim TH; Chang HJ; Kim DY; Jung KH; Hong YS; Kim SY; Park JW; Oh JH; Lim SB; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1158-65. PubMed ID: 19800178
[TBL] [Abstract][Full Text] [Related]
46. [Predictive value of serum carcinoembryonic antigen level in efficacy and prognosis for patients with rectal cancer following preoperative radiochemotherapy].
Zhang D; Zhan T; Li M; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):519-523. PubMed ID: 28534328
[TBL] [Abstract][Full Text] [Related]
47. The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage.
Cai Y; Chen M; Ye F; Liu Z; Luo S; Huang L; Kang L
Eur J Surg Oncol; 2024 Apr; 50(4):108001. PubMed ID: 38364330
[TBL] [Abstract][Full Text] [Related]
48. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
49. Prognostic Impact of Carcinoembryonic Antigen Levels in Rectal Cancer Patients Who Had Received Neoadjuvant Chemoradiotherapy.
Joo JI; Lim SW; Oh BY
Ann Coloproctol; 2021 Jun; 37(3):179-185. PubMed ID: 33971705
[TBL] [Abstract][Full Text] [Related]
50. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
[TBL] [Abstract][Full Text] [Related]
51. Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.
Nakamura Y; Shida D; Tanabe T; Takamizawa Y; Imaizumi J; Ahiko Y; Sakamoto R; Moritani K; Tsukamoto S; Kanemitsu Y
Cancer Med; 2020 Jan; 9(2):653-662. PubMed ID: 31799750
[TBL] [Abstract][Full Text] [Related]
52. Nadir/pre-chemoradiotherapy ratio of white blood-cell count can predict tumor response and recurrence-free survival in locally advanced rectal cancer: a multi-institutional analysis.
Lee JH; Jeong JU; Kim SH; Nam TK; Lee JH; Jeong S; Yu M; Jang HS
Int J Colorectal Dis; 2019 Jan; 34(1):105-112. PubMed ID: 30350135
[TBL] [Abstract][Full Text] [Related]
53. Role of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma: CEA Level Before Operation is a Significant Prognostic Indicator in Patients With Locally Advanced Pancreatic Cancer Treated With Neoadjuvant Therapy Followed by Surgical Resection: A Retrospective Analysis.
Kato H; Kishiwada M; Hayasaki A; Chipaila J; Maeda K; Noguchi D; Gyoten K; Fujii T; Iizawa Y; Tanemura A; Murata Y; Kuriyama N; Usui M; Sakurai H; Isaji S; Mizuno S
Ann Surg; 2022 May; 275(5):e698-e707. PubMed ID: 32744820
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of CEA and CA19-9 in patients with local advanced rectal cancer receiving neoadjuvant chemoradiotherapy, radical surgery and postoperative chemotherapy.
Shan J; Gu B; Shi L; Wang X; Ye W; Zhou W; Sun X
Transl Cancer Res; 2021 Jan; 10(1):88-98. PubMed ID: 35116242
[TBL] [Abstract][Full Text] [Related]
55. Predictors of Early Distant Relapse in Rectal Cancer Patients Submitted to Preoperative Chemoradiotherapy.
Restivo A; Delrio P; Deidda S; Spolverato G; Rega D; Cerci M; Barina A; Perin A; Pace U; Zorcolo L; Pucciarelli S
Oncol Res Treat; 2020; 43(4):146-152. PubMed ID: 32036373
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of postoperative serum carcinoembryonic antigen levels in colorectal cancer patients who smoke.
Huang CS; Chen CY; Huang LK; Wang WS; Yang SH
PLoS One; 2020; 15(6):e0233687. PubMed ID: 32502149
[TBL] [Abstract][Full Text] [Related]
57. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Wolff RA; Eng C; Krishnan S; Janjan NA; Crane CH
Cancer; 2007 May; 109(9):1750-5. PubMed ID: 17387743
[TBL] [Abstract][Full Text] [Related]
58. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
Perez RO; São Julião GP; Habr-Gama A; Kiss D; Proscurshim I; Campos FG; Gama-Rodrigues JJ; Cecconello I
Dis Colon Rectum; 2009 Jun; 52(6):1137-43. PubMed ID: 19581858
[TBL] [Abstract][Full Text] [Related]
59. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
[TBL] [Abstract][Full Text] [Related]
60. Can we optimize CEA as a response marker in rectal cancer?
Gago T; Caldeira P; Cunha AC; Campelo P; Guerreiro H
Rev Esp Enferm Dig; 2021 Jun; 113(6):423-428. PubMed ID: 33228364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
